Treatment outcomes and patterns of radiologic appearance after hypofractionated image-guided radiotherapy delivered with helical tomotherapy (HHT) for lung tumours.

about

Treatment outcomes and patterns of radiologic appearance after hypofractionated image-guided radiotherapy delivered with helical tomotherapy (HHT) for lung tumours.

Item

http://www.wikidata.org/entity/Q50863889

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Treatment outcomes and pattern ...... herapy (HHT) for lung tumours.

@en

Treatment outcomes and pattern ...... vered with helical tomotherapy

@nl

type

Item

label

Treatment outcomes and pattern ...... herapy (HHT) for lung tumours.

@en

Treatment outcomes and pattern ...... vered with helical tomotherapy

@nl

prefLabel

Treatment outcomes and pattern ...... herapy (HHT) for lung tumours.

@en

Treatment outcomes and pattern ...... vered with helical tomotherapy

@nl

P1476

Treatment outcomes and pattern ...... herapy (HHT) for lung tumours.

@en

P2093

Alessandro Greco

http://www.w3.org/2001/XMLSchema#string

Alessia Monaco

http://www.w3.org/2001/XMLSchema#string

Cinzia Chiostrini

http://www.w3.org/2001/XMLSchema#string

Cynthia Aristei

http://www.w3.org/2001/XMLSchema#string

Jessica Dognini

http://www.w3.org/2001/XMLSchema#string

Lorenzo Falcinelli

http://www.w3.org/2001/XMLSchema#string

Rita Bellavita

http://www.w3.org/2001/XMLSchema#string

Stefano Arcangeli

http://www.w3.org/2001/XMLSchema#string

Stefano Bracci

http://www.w3.org/2001/XMLSchema#string

Vittorio Donato

http://www.w3.org/2001/XMLSchema#string

P2860

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Patterns of CT lung injury and toxicity after stereotactic radiotherapy delivered with helical tomotherapy in early stage medically inoperable NSCLC

Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.

The lessons of QUANTEC: recommendations for reporting and gathering data on dose-volume dependencies of treatment outcome.

Outcome and toxicity of stereotactic body radiotherapy with helical tomotherapy for inoperable lung tumor: analysis of Grade 5 radiation pneumonitis.

Which is the optimal biologically effective dose of stereotactic body radiotherapy for Stage I non-small-cell lung cancer? A meta-analysis.

Stereotactic body radiation therapy for inoperable early stage lung cancer.

Improving outcomes for high-risk patients with early-stage non-small-cell lung cancer: insights from population-based data and the role of stereotactic ablative radiotherapy.

Stereotactic body radiotherapy with helical TomoTherapy for medically inoperable early stage primary and second-primary non-small-cell lung neoplasm: 1-year outcome and toxicity analysis

Can stereotactic fractionated radiation therapy become the standard of care for early stage non-small cell lung carcinoma.

P304

20160853

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1259/BJR.20160853

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

1071

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28256158

http://www.w3.org/2001/XMLSchema#string

P932

5601537

http://www.w3.org/2001/XMLSchema#string